NasdaqGM - Delayed Quote USD
Nurix Therapeutics, Inc. (NRIX)
12.78
+0.28
+(2.24%)
At close: June 6 at 4:00:00 PM EDT
12.78
0.00
(0.00%)
After hours: June 6 at 5:59:47 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 846,366 | 9 |
| Sales | 41,973 | 10 |
| Net Shares Purchased (Sold) | 804,393 | 19 |
| Total Insider Shares Held | 1.07M | -- |
| % Net Shares Purchased (Sold) | 298.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale at price 11.33 per share. | Direct | 70,243 | May 2, 2025 |
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale at price 11.50 per share. | Direct | 28,041 | Apr 30, 2025 |
| HANSEN GWENN Officer | Sale at price 11.50 per share. | Direct | 38,841 | Apr 30, 2025 |
| RING CHRISTINE Officer | Sale at price 11.50 per share. | Direct | 33,286 | Apr 30, 2025 |
| VAN HOUTE JOHANNES D Chief Financial Officer | -- | Direct | -- | Apr 30, 2025 |
| HANSEN GWENN Officer | -- | Direct | -- | Apr 30, 2025 |
| RING CHRISTINE Officer | -- | Direct | -- | Apr 30, 2025 |
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale at price 14.40 - 15.13 per share. | Direct | 84,388 | Mar 3, 2025 |
| RING CHRISTINE Officer | Sale at price 19.94 - 20.48 per share. | Direct | 114,934 | Jan 31, 2025 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 1.86 per share. | Direct | 10,714 | Jan 31, 2025 |
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale at price 19.81 - 20.33 per share. | Direct | 55,809 | Jan 30, 2025 |
| HANSEN GWENN Officer | Sale at price 19.81 - 20.33 per share. | Direct | 73,260 | Jan 30, 2025 |
| RING CHRISTINE Officer | Sale at price 19.81 - 20.33 per share. | Direct | 63,929 | Jan 30, 2025 |
| VAN HOUTE JOHANNES D Chief Financial Officer | -- | Direct | -- | Jan 30, 2025 |
| HANSEN GWENN Officer | -- | Direct | -- | Jan 30, 2025 |
| RING CHRISTINE Officer | -- | Direct | -- | Jan 30, 2025 |
| RING CHRISTINE Officer | Sale at price 19.50 per share. | Direct | 112,295 | Jan 2, 2025 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 1.86 per share. | Direct | 10,714 | Jan 2, 2025 |
| RING CHRISTINE Officer | Sale at price 21.73 per share. | Direct | 125,155 | Dec 2, 2024 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 1.86 per share. | Direct | 10,714 | Dec 2, 2024 |
| RING CHRISTINE Officer | Sale at price 25.00 per share. | Direct | 82,250 | Nov 4, 2024 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 9.57 per share. | Direct | 31,485 | Nov 4, 2024 |
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale at price 24.28 per share. | Direct | 86,083 | Nov 1, 2024 |
| RING CHRISTINE Officer | Sale at price 24.28 per share. | Direct | 139,867 | Nov 1, 2024 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 1.86 per share. | Direct | 10,714 | Nov 1, 2024 |
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale at price 24.30 per share. | Direct | 57,554 | Oct 30, 2024 |
| HANSEN GWENN Officer | Sale at price 24.30 per share. | Direct | 83,536 | Oct 30, 2024 |
| RING CHRISTINE Officer | Sale at price 24.30 per share. | Direct | 101,644 | Oct 30, 2024 |
| VAN HOUTE JOHANNES D Chief Financial Officer | -- | Direct | -- | Oct 30, 2024 |
| HANSEN GWENN Officer | -- | Direct | -- | Oct 30, 2024 |
| RING CHRISTINE Officer | -- | Direct | -- | Oct 30, 2024 |
| RING CHRISTINE Officer | Sale at price 25.00 per share. | Direct | 82,250 | Oct 14, 2024 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 9.57 per share. | Direct | 31,485 | Oct 14, 2024 |
| RING CHRISTINE Officer | Sale at price 22.19 - 22.81 per share. | Direct | 128,017 | Oct 1, 2024 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 1.86 per share. | Direct | 10,714 | Oct 1, 2024 |
| RING CHRISTINE Officer | Sale at price 24.93 - 25.62 per share. | Direct | 225,736 | Sep 3, 2024 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 1.86 - 9.57 per share. | Direct | 42,199 | Sep 3, 2024 |
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale at price 25.22 per share. | Direct | 504,370 | Aug 26, 2024 |
| RING CHRISTINE Officer | Sale at price 25.01 per share. | Direct | 246,843 | Aug 26, 2024 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 1.86 - 9.57 per share. | Direct | 60,046 | Aug 26, 2024 |
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale at price 21.43 - 22.22 per share. | Direct | 74,576 | Aug 1, 2024 |
| RING CHRISTINE Officer | Sale at price 21.39 - 22.18 per share. | Direct | 123,459 | Aug 1, 2024 |
| RING CHRISTINE Officer | Conversion of Exercise of derivative security at price 1.86 per share. | Direct | 10,714 | Aug 1, 2024 |
| VAN HOUTE JOHANNES D Chief Financial Officer | Sale at price 20.67 per share. | Direct | 51,463 | Jul 30, 2024 |
| HANSEN GWENN Officer | Sale at price 20.67 per share. | Direct | 70,436 | Jul 30, 2024 |
| RING CHRISTINE Officer | Sale at price 20.67 per share. | Direct | 60,350 | Jul 30, 2024 |
| VAN HOUTE JOHANNES D Chief Financial Officer | -- | Direct | -- | Jul 30, 2024 |
| HANSEN GWENN Officer | -- | Direct | -- | Jul 30, 2024 |
| RING CHRISTINE Officer | -- | Direct | -- | Jul 30, 2024 |
| KUNKEL LORI ANNE Director | Stock Gift at price 0.00 per share. | Direct | 0 | Jul 17, 2024 |
Related Tickers
RLAY Relay Therapeutics, Inc.
3.3600
+3.70%
RVMD Revolution Medicines, Inc.
41.09
+2.21%
BCAX Bicara Therapeutics Inc.
11.50
+4.26%
CCCC C4 Therapeutics, Inc.
1.7300
+17.69%
PTGX Protagonist Therapeutics, Inc.
54.38
+1.04%
ANAB AnaptysBio, Inc.
23.70
+12.11%
SRRK Scholar Rock Holding Corporation
34.23
-0.06%
RCUS Arcus Biosciences, Inc.
9.97
+3.53%
ORIC ORIC Pharmaceuticals, Inc.
9.32
+1.75%
IMTX Immatics N.V.
5.97
+3.29%